Metformin associated with photodynamic therapy – A novel oncological direction

Hursting, 2010, Energy balance, host-related factors, and cancer progression, J. Clin. Oncol., 28, 4058, 10.1200/JCO.2010.27.9935 Witters, 2001, The blooming of the French lilac, J. Clin. Invest., 108, 1105, 10.1172/JCI14178 Bailey, 1996, Metformin, N. Engl. J. Med., 334, 574, 10.1056/NEJM199602293340906 Zakikhani, 2006, Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells, Cancer Res., 66, 10269, 10.1158/0008-5472.CAN-06-1500 Chen, 2012, Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents, J. Clin. Endocrinol. Metab., 97, 10.1210/jc.2011-1754 Hirsch, 2009, Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumour growth and prolong remission, Cancer Res., 69, 7507, 10.1158/0008-5472.CAN-09-2994 Agostinis, 2011, Photodynamic therapy of cancer: an update, CA Cancer J. Clin., 61, 250, 10.3322/caac.20114 Pascu, 2003, Spectroscopic characteristics of metalloporphyrins used in photodynamic therapy, Oftalmologia, 57, 73 Ion, 1996, Spectral studies of TSPP and TSNP used in PDT. Monomer-dimer equilibrium, Rom. J. Biophys., 6, 213 Filip, 2011, The effects of grape seeds polyphenols on SKH-1 mice skin irradiated with multiple doses of UV-B, J. Photochem. Photobiol., B, 105, 133, 10.1016/j.jphotobiol.2011.08.002 Noble, 2000, Quantitation of protein, Methods Enzymol., 463, 73, 10.1016/S0076-6879(09)63008-1 Conti, 1991, Improved fluorimetric determination of malondialdehyde, Clin. Chem., 37, 1273, 10.1093/clinchem/37.7.1273 Reznick, 1994, Oxidative damage to proteins: spectrophotometric method for carbonyl assay, Methods Enzymol., 233, 357, 10.1016/S0076-6879(94)33041-7 Hu, 1994, Measurement of protein thiol groups and glutathione in plasma, Methods Enzymol., 233, 380, 10.1016/S0076-6879(94)33044-1 Titheradge, 1998, The enzymatic measurement of nitrate and nitrite, Methods Mol. Biol., 100, 83 Filip, 2012, Calluna Vulgaris extract modulates NF-kB/ERK 1/2 signaling pathway and MMP expression in SKH-1 hairless mice skin exposed to UVB, J. Physiol. Pharmacol., 63, 423 Aaltomaa, 2000, The prognostic value of inducible nitric oxide synthase in local prostate cancer, BJU Int., 86, 234, 10.1046/j.1464-410x.2000.00787.x Bolfa, 2013, Photoprotective effects of Romanian propolis on skin of mice exposed to UVB irradiation, Food Chem. Toxicol., 62, 329, 10.1016/j.fct.2013.08.078 Dowling, 2011, Understanding the benefit of metformin use in cancer treatment, BMC Med., 9, 33, 10.1186/1741-7015-9-33 Evans, 2005, Metformin and reduced risk of cancer in diabetic patients, BMJ, 330, 1304, 10.1136/bmj.38415.708634.F7 Vazquez-Martin, 2010, Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial–mesenchymal transition (EMT) status, Cell Cycle, 9, 3807, 10.4161/cc.9.18.13131 Anisimov, 2005, Effect of metformin on life span and on the development of spontaneous mammary tumours in HER-2/neu transgenic mice, Exp. Gerontol., 40, 685, 10.1016/j.exger.2005.07.007 Fonseca, 2011, Metformin reduces the stimulatory effect of obesity on in vivo Walker-256 tumour development and increases the area of tumour necrosis, Life Sci., 88, 846, 10.1016/j.lfs.2011.03.005 Hadad, 2011, Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial, Breast Cancer Res. Treat., 128, 783, 10.1007/s10549-011-1612-1 Hosono, 2010, Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial, Cancer Prev. Res. (Phila.), 3, 1077, 10.1158/1940-6207.CAPR-10-0186 Patel, 2010, Clinical outcomes after radical prostatectomy in diabetic patients treated with metformin, Urology, 76, 1240, 10.1016/j.urology.2010.03.059 Zepp, 1986, Degradation of insulin and glucagon by a factor associated with Walker 256 carcinosarcoma cells, Cancer Lett., 31, 77, 10.1016/0304-3835(86)90169-2 Buytaert, 2007, Molecular effectors of multiple cell death pathways initiated by photodynamic therapy, Biochim. Biophys. Acta, 1776, 86 Constantin, 2004, The effect of laser activation of 5, 10, 15, 20-tetra-sulphophenyl-porphyrin loaded in K562 cells and human normal mononuclear cells, Roum. Arch. Microbiol. Immunol., 63, 159 Clichici, 2010, The dynamics of reactive oxygen species in photodynamic therapy with tetra sulfophenyl-porphyrin, Acta Physiol. Hung., 97, 41, 10.1556/APhysiol.97.2010.1.5 Algire, 2012, Metformin reduces endogenous reactive oxygen species and associated DNA damage, Cancer Prev. Res. (Phila.), 5, 536, 10.1158/1940-6207.CAPR-11-0536 Mehta, 2009, Cytoprotective mechanisms of carbonyl scavenging drugs in isolated rat hepatocytes, Chem. Biol. Interact., 178, 317, 10.1016/j.cbi.2008.10.026 Belgorosky, 2013, Inhibition of nitric oxide is a good therapeutic target for bladder tumours that express iNOS, Nitric Oxide C, 36, 11, 10.1016/j.niox.2013.10.010 Gately, 2000, The contributions of cyclooxygenase-2 to tumour angiogenesis, Cancer Metastasis Rev., 19, 19, 10.1023/A:1026575610124 Cerezo, 2013, Metformin blocks melanoma invasion and metastasis development in AMPK/p53-dependent manner, Mol. Cancer Ther., 12, 1605, 10.1158/1535-7163.MCT-12-1226-T Hirsch, 2013, Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth, Proc. Natl. Acad. Sci. U. S. A., 110, 972, 10.1073/pnas.1221055110 Wang, 2008, Metformin induces apoptosis of pancreatic cancer cells, World J. Gastroenterol., 14, 7192, 10.3748/wjg.14.7192 Zheng, 2013, Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma, Clin. Cancer Res., 19, 5372, 10.1158/1078-0432.CCR-13-0203 Alimova, 2009, Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro, Cell Cycle, 8, 909, 10.4161/cc.8.6.7933 Barathan, 2013, Hypericin–photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases, Cell Death Dis., 4, e697, 10.1038/cddis.2013.219 Yasmeen, 2011, Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the Bcl-2 family proteins, Gynecol. Oncol., 121, 492, 10.1016/j.ygyno.2011.02.021 Zou, 2004, Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species, J. Biol. Chem., 279, 43940, 10.1074/jbc.M404421200 Zhou, 2001, Role of AMP-activated protein kinase in mechanism of metformin action, J. Clin. Invest., 108, 1167, 10.1172/JCI13505 Towler, 2007, AMP-activated protein kinase in metabolic control and insulin signaling, Circ. Res., 100, 328, 10.1161/01.RES.0000256090.42690.05